AI assistant
TransMedics Group, Inc. — Director's Dealing 2024
Aug 9, 2024
31201_dirs_2024-08-09_6ea5f39b-dbd1-422a-bab2-b06565ab6c00.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2024-06-05
Reporting Person: Ranganath Anil P. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-05 | Common Stock | S | 703 | $135.21 | Disposed | 8809 | Direct |
| 2024-08-07 | Common Stock | M | 4289 | $93.88 | Acquired | 13182 | Direct |
| 2024-08-07 | Common Stock | S | 4289 | $152.20 | Disposed | 8893 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-08-07 | Stock Option (Right to Buy) | $93.88 | M | 4289 | Disposed | 2033-08-01 | Common Stock (4289) | Direct |
Footnotes
F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.
F2: Includes 84 shares of Issuer's Common Stock acquired on June 28, 2024, pursuant to the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan ("ESPP"), for the option period of January 2, 2024 to June 28, 2024. This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on January 2, 2024.
F3: The option vested as to 25% on June 5, 2024 and will vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.